Showing results (111-120 of 219) with videos related to

Sort By:
Pageof 22
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2010
Phase II trial of neoadjuvant temozolomide in resectable melanoma patientsG D Shah, N D Socci, J S Gold, et al.
Cancer Chemotherapy and Pharmacology|October 19, 2010
A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridolMark A Dickson, Manish A Shah, Dana Rathkopf, et al.
Gastrointestinal Cancer Research : GCR|January 8, 2013
A Nonrandomized, Phase II Study of Sequential Irinotecan and Flavopiridol in Patients With Advanced Hepatocellular CarcinomaCelina Ang, Eileen M O'Reilly, Richard D Carvajal, et al.
Clinical Nuclear Medicine|February 29, 2020
FLT-PET At 6 Weeks Predicts Response Assessed by CT at 12 Weeks in Melanoma Patients Treated With PembrolizumabRandy Yeh, Megan H Trager, Emanuelle M Rizk, et al.
Nature Reviews. Clinical Oncology|January 4, 2023
Advances in the clinical management of uveal melanomaRichard D Carvajal, Joseph J Sacco, Martine J Jager, et al.
Parasitology Research|January 15, 2021
Ticks (Acari: Ixodoidea) associated with mammals in Colombia: a historical review, molecular species confirmation, and establishment of new relationshipsMateo Ortíz-Giraldo, William D Tobón-Escobar, Daniela Velásquez-Guarín, et al.
JCO Precision Oncology|January 20, 2022
Clinical Utilization, Utility, and Reimbursement for Expanded Genomic Panel Testing in Adult OncologySusan J Hsiao, Anthony N Sireci, Danielle Pendrick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
A first-in-human phase I study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumorsLuis A Diaz, Christina M Coughlin, Susan C Weil, et al.
Cancer|February 10, 2010
Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survivalGeoffrey Y Ku, Jianda Yuan, David B Page, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2014
A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanomaRichard D Carvajal, Michael K Wong, John A Thompson, et al.
Pageof 22